Saudi Chemical Co. announces its Annual Financial Results for the Period Ending on 2022-12-31
| Element List | Current Year | Previous Year | %Change | ||
|---|---|---|---|---|---|
| Sales/Revenue | 3,696 | 3,411 | 8.36 | ||
| Gross Profit (Loss) | 488 | 432 | 12.96 | ||
| Operational Profit (Loss) | 177 | 142 | 24.65 | ||
| Net Profit (Loss) after Zakat and Tax | 80 | 70 | 14.29 | ||
| Total Comprehensive Income | 84 | 72 | 16.67 | ||
| Total Share Holders Equity (after Deducting Minority Equity) | 1,660 | 1,618 | 2.6 | ||
| Profit (Loss) per Share | 0.95 | 0.83 | |||
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the net profit during the current year compared to the last year is | The increase in net income is due to the increase in pharma sector sales and explosive sector sales, alongside an improvement in gross profit and the revaluation gains on derivative financial instruments related to interest rate exposure, despite the increase in expected credit loss on trade receivables, the increase in finance costs, and foreign currency revaluation. |
| Statement of the type of external auditor's report | Unmodified opinion |
| Reclassification of Comparison Items | Certain comparative figures have been reclassified to conform with current year presentation. |
Comments